logo

For the Inventor, By the Inventor

Seoul, South Korea

Good T Cells, Inc.


USPTO Granted Patents = 14


Forward Citations = 1

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Beom Seok Kim (8 out of 38 patents)

silverMedal Jung Ho Kim (8 out of 122 patents)

bronzeMedal Sang-Kyou Lee (6 out of 11 patents)

4.  Sung-Dong Park (3 out of 3 patents)

5.  Chin Hee Mun (1 out of 1 patent)

6.  Sang Won Lee (1 out of 90 patents)

7.  Ye Kyung Seong (1 patent)

8.  Jen Young Cho (1 patent)

9.  Sang Hwa Yang (1 patent)

10.  Jong Hyun Park (71 patents)

11.  Tae Yoon Park (0 patent)


14 patents:

1. 11999785 - Binding molecule specific for Lrig-1 protein and use thereof (2024-06-04),
2. 11969463 - Method for activating T cells for cancer treatment (2024-04-30),
3. 11932686 - Use of regulatory T cell-specific surface protein LRIG-1 (2024-03-19),
4. 11918634 - Method for activating T cells for cancer treatment (2024-03-05),
5. 11890364 - Composition for prevention or treatment of hair loss (2024-02-06),
6. 11820801 - Fusion protein, and pharmaceutical composition for preventing or treating cancer, containing same (2023-11-21),
7. 11655287 - Use of regulatory T cell-specific surface protein LRIG-1 (2023-05-23),
8. 11414467 - Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereof (2022-08-16),
9. 11365249 - Binding molecule specific for Lrig-1 protein and use thereof (2022-06-21),
10. 11345729 - Recombinant fusion protein of BAF57 and uses thereof (2022-05-31),
11. 11279756 - Binding molecule specific for LRIG-1 protein and use thereof (2022-03-22),
12. 11091538 - Use of regulatory T cell-specific surface protein LRIG-1 (2021-08-17),
13. 10544196 - Composition containing SMAD protein for treatment of autoimmune diseases, a fusion protein comprising SMAD protein, an expression vector and a method for preparing the same (2020-01-28),
14. 10494411 - Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereof (2019-12-03),
Good T Cells, Inc. is a biotechnology company specializing in the development of innovative immunotherapies for various types of cancers. Our proprietary technology focuses on harnessing the power of T cells to target and destroy cancer cells. We strive to make a meaningful impact in the fight against cancer and improve the quality of life for patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

14 Patents

#293 in Seoul

#823 in South Korea

#42,135 in the World

Seoul, KR
Seoul, South Korea

Good T Cells, Inc.

Forward Citations = 1

6 inventors:

goldMedal Beom Seok Kim (8 out of 38 patents)

silverMedal Jung Ho Kim (8 out of 122 patents)

bronzeMedal Sang-Kyou Lee (6 out of 11 patents)

4.  Sung-Dong Park (3 out of 3 patents)

5.  Chin Hee Mun (1 out of 1 patent)

Please report any incorrect information to [email protected]
Loading…